Table 5. Relative risk* and 95% confidence intervals of dying or being lost from treatment.
| Relative risk of dying | Relative risk of loss from treatment | ||||
|---|---|---|---|---|---|
| IRR | 95% CI | IRR | 95% CI | ||
| Sex | Male | 1.14 | 0.40–3.23 | 0.42 | 0.17–1.03 |
| Age category | Age 18–29 | 1.22 | 0.34–4.34 | 1.5 | 0.62–3.64 |
| Age 30–49 | Reference | Reference | |||
| Age 50+ | 2.17 | 0.52–9.09 | 0.67 | 0.09–4.69 | |
| HIV infection (ART) | HIV-negative | Reference | Reference | ||
| HIV+ on ART | 2.03 | 0.27–15.29 | 2.79 | 0.38–20.35 | |
| HIV+ not on ART | 1.22 | 0.14–10.31 | 2.44 | 0.32–13.35 | |
| HIV infection (CD4) | HIV-negative | Reference | Reference | ||
| HIV+ CD4>100 | 1 | 0.12–8.47 | 2.25 | 0.30–16.75 | |
| HIV+ CD4≤ 100 | 2.48 | 0.33–18.67 | 3.10 | 0.42–22.78 | |
| Body mass index | Low BMI <18.5 | 1.03 | 0.13–8.10 | 0.48 | 0.07–3.43 |
| Anaemia | No anaemia | Reference | Reference | ||
| Mild or moderate | 1.28 | 0.34–4.85 | 0.71 | 0.26–1.98 | |
| Severe | 5.16 | 1.40–19.04 | 0.76 | 0.11–5.30 | |
| Initiation model | Inpatient | 1.92 | 0.68–5.43 | 2.01 | 0.89–4.55 |
| Time to initiation | ≤ 1 week | 1.04 | 0.24–4.47 | 0.30 | 0.09–0.98 |
| Pulmonary TB | PTB site | All deaths PTB | 0.52 | 0.20–1.38 | |
| Sputum microscopy | AFB+ | 2.21 | 0.67–7.27 | 0.63 | 0.22–1.81 |
| TB history | Prior TB | 0.67 | 0.22–2.09 | 1.01 | 0.44–2.32 |
| Kidney function | Normal | Reference | Reference | ||
| Mild dysfunction | 0.41 | 0.13–1.31 | 1.10 | 0.32–3.84 | |
| Moderate dysfunction | 0.31 | 0.06–1.46 | 1.53 | 0.42–5.58 | |
* Relative risk calculated using Poisson regression with robust standard errors
Statistically significant differences bolded.